enavogliflozin 0.3mg

DRUG2 trials

Sponsors

Yonsei University, Seoul St. Mary's Hospital

Conditions

Amyloid CardiomyopathyNonobstructive Hypertrophic Cardiomyopathy

Phase 4

ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy

RecruitingNCT06580717

Yonsei UniversityNonobstructive Hypertrophic Cardiomyopathy

Start: 2024-10-15End: 2026-11-30Target: 200Updated: 2024-11-08

Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy

RecruitingNCT07240844

Seoul St. Mary's HospitalAmyloid Cardiomyopathy

Start: 2026-01-06End: 2027-05-31Target: 68Updated: 2026-06-18